158 related articles for article (PubMed ID: 18559486)
1. Blood monocyte-derived neohepatocytes as in vitro test system for drug metabolism.
Ehnert S; Nussler AK; Lehmann A; Dooley S
Drug Metab Dispos; 2008 Sep; 36(9):1922-9. PubMed ID: 18559486
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
Westerink WM; Schoonen WG
Toxicol In Vitro; 2007 Dec; 21(8):1581-91. PubMed ID: 17637504
[TBL] [Abstract][Full Text] [Related]
3. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells.
Aninat C; Piton A; Glaise D; Le Charpentier T; Langouët S; Morel F; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2006 Jan; 34(1):75-83. PubMed ID: 16204462
[TBL] [Abstract][Full Text] [Related]
4. In vitro drug metabolism testing using blood-monocyte derivatives.
Gómez-Icazbalceta G; González-Sánchez I; Moreno J; Cerbón MA; Cervantes A
Expert Opin Drug Metab Toxicol; 2013 Dec; 9(12):1571-80. PubMed ID: 23984653
[TBL] [Abstract][Full Text] [Related]
5. Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
Westerink WM; Schoonen WG
Toxicol In Vitro; 2007 Dec; 21(8):1592-602. PubMed ID: 17716855
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of the P450 inhibition and induction potential of daptomycin in primary human hepatocytes.
Oleson FB; Berman CL; Li AP
Chem Biol Interact; 2004 Nov; 150(2):137-47. PubMed ID: 15535984
[TBL] [Abstract][Full Text] [Related]
7. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar.
Zhang D; Wang L; Chandrasena G; Ma L; Zhu M; Zhang H; Davis CD; Humphreys WG
Drug Metab Dispos; 2007 Jan; 35(1):139-49. PubMed ID: 17062778
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells.
Reilly CA; Ehlhardt WJ; Jackson DA; Kulanthaivel P; Mutlib AE; Espina RJ; Moody DE; Crouch DJ; Yost GS
Chem Res Toxicol; 2003 Mar; 16(3):336-49. PubMed ID: 12641434
[TBL] [Abstract][Full Text] [Related]
9. Molecular and functional characterization of drug-metabolizing enzymes and transporter expression in the novel spontaneously immortalized human hepatocyte line HC-04.
Lim PL; Tan W; Latchoumycandane C; Mok WC; Khoo YM; Lee HS; Sattabongkot J; Beerheide W; Lim SG; Tan TM; Boelsterli UA
Toxicol In Vitro; 2007 Dec; 21(8):1390-401. PubMed ID: 17590308
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of phase I and II enzyme activities in 5 hepatic cell lines identifies Huh-7 and HCC-T cells with the highest potential to study drug metabolism.
Lin J; Schyschka L; Mühl-Benninghaus R; Neumann J; Hao L; Nussler N; Dooley S; Liu L; Stöckle U; Nussler AK; Ehnert S
Arch Toxicol; 2012 Jan; 86(1):87-95. PubMed ID: 21735230
[TBL] [Abstract][Full Text] [Related]
11. Human monocyte-derived neohepatocytes: a promising alternative to primary human hepatocytes for autologous cell therapy.
Ruhnke M; Nussler AK; Ungefroren H; Hengstler JG; Kremer B; Hoeckh W; Gottwald T; Heeckt P; Fandrich F
Transplantation; 2005 May; 79(9):1097-103. PubMed ID: 15880050
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of liposomal curcumin cytochrome p450 metabolism.
Mach CM; Chen JH; Mosley SA; Kurzrock R; Smith JA
Anticancer Res; 2010 Mar; 30(3):811-4. PubMed ID: 20393001
[TBL] [Abstract][Full Text] [Related]
13. Expression of drug metabolizing enzymes in hepatocyte-like cells derived from human embryonic stem cells.
Ek M; Söderdahl T; Küppers-Munther B; Edsbagge J; Andersson TB; Björquist P; Cotgreave I; Jernström B; Ingelman-Sundberg M; Johansson I
Biochem Pharmacol; 2007 Aug; 74(3):496-503. PubMed ID: 17568565
[TBL] [Abstract][Full Text] [Related]
14. Autologous serum improves yield and metabolic capacity of monocyte-derived hepatocyte-like cells: possible implication for cell transplantation.
Ehnert S; Seeliger C; Vester H; Schmitt A; Saidy-Rad S; Lin J; Neumaier M; Gillen S; Kleeff J; Friess H; Burkhart J; Stöckle U; Nüssler AK
Cell Transplant; 2011; 20(9):1465-77. PubMed ID: 21294943
[TBL] [Abstract][Full Text] [Related]
15. Expression and induction potential of cytochromes P450 in human cryopreserved hepatocytes.
Roymans D; Annaert P; Van Houdt J; Weygers A; Noukens J; Sensenhauser C; Silva J; Van Looveren C; Hendrickx J; Mannens G; Meuldermans W
Drug Metab Dispos; 2005 Jul; 33(7):1004-16. PubMed ID: 15802389
[TBL] [Abstract][Full Text] [Related]
16. Sexually dimorphic regulation of hepatic isoforms of human cytochrome p450 by growth hormone.
Dhir RN; Dworakowski W; Thangavel C; Shapiro BH
J Pharmacol Exp Ther; 2006 Jan; 316(1):87-94. PubMed ID: 16160083
[TBL] [Abstract][Full Text] [Related]
17. Effect of colchicine and its derivatives on the expression of selected isoforms of cytochrome P450 in primary cultures of human hepatocytes.
Dvorák Z; Ulrichová J; Modrianský M; Maurel P
Acta Univ Palacki Olomuc Fac Med; 2000; 143():47-50. PubMed ID: 11144118
[TBL] [Abstract][Full Text] [Related]
18. Liver grafts preserved in Celsior solution as source of hepatocytes for drug metabolism studies: comparison with surgical liver biopsies.
Donato MT; Serralta A; Jiménez N; Pérez G; Castell JV; Mir J; Gómez-Lechón MJ
Drug Metab Dispos; 2005 Jan; 33(1):108-14. PubMed ID: 15448115
[TBL] [Abstract][Full Text] [Related]
19. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.
Guillouzo A; Corlu A; Aninat C; Glaise D; Morel F; Guguen-Guillouzo C
Chem Biol Interact; 2007 May; 168(1):66-73. PubMed ID: 17241619
[TBL] [Abstract][Full Text] [Related]
20. Human cytochrome p450 enzyme specificity for the bioactivation of estragole and related alkenylbenzenes.
Jeurissen SM; Punt A; Boersma MG; Bogaards JJ; Fiamegos YC; Schilter B; van Bladeren PJ; Cnubben NH; Rietjens IM
Chem Res Toxicol; 2007 May; 20(5):798-806. PubMed ID: 17407329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
